黑色素细胞痣的全基因组分子谱分析
该研究对14例良性黑色素细胞痣(含先天性与获得性)行全基因组测序,全部痣均携带MAPK通路驱动突变(BRAF V600E或NRAS Q61R/L),未发现其他明确驱动突变;高突变负荷痣以UVR相关突变特征7a/7b为主,低负荷痣(含全部3例先天性痣)以特征1/5为主。部分痣存在TERT启动子亚克隆突变。
要点
- 所有良性痣均由BRAF V600E或NRAS Q61R/L驱动MAPK通路。
- 高突变负荷痣以UVR相关突变特征7a/7b为主。
- 形态学良性痣可存在TERT启动子亚克隆突变,影响生物标志物解读。
核心结论
- 良性黑色素细胞痣的驱动突变集中于MAPK通路,UVR参与部分痣的病因,TERT启动子突变可在形态学良性痣中以亚克隆形式存在。
研究设计与样本
- 对14例良性黑色素细胞痣(包括先天性和获得性类型)进行全基因组测序。
主要发现
- 所有痣均携带MAPK信号通路驱动突变,为BRAF V600E或NRAS Q61R/L。
- 未发现其他明确的驱动突变。
- 高突变负荷痣以突变特征7a和7b为主,与UVR暴露一致。
- 低突变负荷痣(包括全部3例先天性痣)以普遍存在的特征1和5为主。
- 2例痣存在预测结合E26转化特异性家族转录因子的启动子区域突变,以及TERT启动子的亚克隆突变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The benign melanocytic nevus is the most common tumor in humans and rarely transforms into cutaneous melanoma. Elucidation of the nevus genome is required to better understand the molecular steps of progression to melanoma. We performed whole genome sequencing on a series of 14 benign melanocytic nevi consisting of both congenital and acquired types. All nevi had driver mutations in the MAPK signaling pathway, either BRAF V600E or NRAS Q61R/L. No additional definite driver mutations were identified. Somatic mutations in nevi with higher mutation loads showed a predominance of mutational signatures 7a and 7b, consistent with UVR exposure, whereas nevi with lower mutation loads (including all three congenital nevi) had a predominance of the ubiquitous signatures 1 and 5. Two nevi had mutations in promoter regions predicted to bind E26 transformation-specific family transcription factors, as well as subclonal mutations in the TERT promoter. This paper presents whole genome data from melanocytic nevi. We confirm that UVR is involved in the etiology of a subset of nevi. This study also establishes that TERT promoter mutations are present in morphologically benign skin nevi in subclonal populations, which has implications regarding the interpretation of this emerging biomarker in sensitive assays.
引用
- Colebatch AJ, Ferguson P, Newell F, et al. Molecular Genomic Profiling of Melanocytic Nevi. J Invest Dermatol. 2019. PMID: 30772300. doi:10.1016/j.jid.2018.12.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。